Toronto Dominion Bank Has $8.90 Million Stock Holdings in The Clorox Company (NYSE:CLX)

Toronto Dominion Bank reduced its position in The Clorox Company (NYSE:CLX - Free Report) by 16.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 54,767 shares of the company's stock after selling 10,977 shares during the period. Toronto Dominion Bank's holdings in Clorox were worth $8,895,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in the company. Integral Investment Advisors Inc. increased its position in shares of Clorox by 4.1% in the fourth quarter. Integral Investment Advisors Inc. now owns 1,718 shares of the company's stock worth $279,000 after acquiring an additional 67 shares in the last quarter. Sound View Wealth Advisors Group LLC increased its position in shares of Clorox by 6.1% in the fourth quarter. Sound View Wealth Advisors Group LLC now owns 1,345 shares of the company's stock worth $218,000 after acquiring an additional 77 shares in the last quarter. Wedbush Securities Inc. boosted its holdings in shares of Clorox by 1.2% during the fourth quarter. Wedbush Securities Inc. now owns 7,624 shares of the company's stock worth $1,238,000 after purchasing an additional 94 shares during the period. Brooklyn Investment Group grew its position in Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company's stock valued at $25,000 after purchasing an additional 95 shares in the last quarter. Finally, Global X Japan Co. Ltd. grew its position in Clorox by 3.0% during the fourth quarter. Global X Japan Co. Ltd. now owns 3,272 shares of the company's stock valued at $531,000 after purchasing an additional 95 shares in the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, Director Pierre R. Breber acquired 4,000 shares of the firm's stock in a transaction on Wednesday, May 7th. The shares were purchased at an average price of $136.57 per share, with a total value of $546,280.00. Following the acquisition, the director now directly owns 4,000 shares in the company, valued at $546,280. The trade was a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link. Insiders own 0.57% of the company's stock.

Clorox Stock Performance

NYSE:CLX traded up $0.07 during trading hours on Friday, hitting $130.97. 1,243,078 shares of the company traded hands, compared to its average volume of 1,331,829. The stock has a market capitalization of $16.14 billion, a price-to-earnings ratio of 35.78, a P/E/G ratio of 2.62 and a beta of 0.60. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The firm has a 50-day moving average of $139.64 and a 200 day moving average of $152.39. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.57 by ($0.12). Clorox had a net margin of 6.38% and a return on equity of 316.87%. The business had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.74 billion. During the same period last year, the firm earned $1.71 EPS. The company's quarterly revenue was down 8.0% compared to the same quarter last year. On average, analysts forecast that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd were issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.73%. The ex-dividend date was Wednesday, April 23rd. Clorox's dividend payout ratio is currently 87.61%.

Wall Street Analyst Weigh In

A number of brokerages recently commented on CLX. Citigroup lowered their price objective on shares of Clorox from $165.00 to $150.00 and set a "neutral" rating on the stock in a research report on Monday, April 14th. Morgan Stanley lowered their price objective on shares of Clorox from $165.00 to $150.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th. DA Davidson lowered their price objective on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 5th. JPMorgan Chase & Co. lowered their price objective on shares of Clorox from $151.00 to $144.00 and set a "neutral" rating on the stock in a research report on Tuesday, May 6th. Finally, Royal Bank of Canada reiterated a "sector perform" rating and issued a $150.00 target price on shares of Clorox in a research note on Thursday, January 30th. Three investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $151.23.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.